NeueHealth, Inc.
NEUE
$4.82
-$1.81-27.25%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 35.52% | 46.92% | 94.45% | 282.53% | 112.61% |
| Total Other Revenue | -18.37% | -7.62% | 16.19% | 35.64% | 89.40% |
| Total Revenue | -9.01% | 1.35% | 26.91% | 54.53% | 206.31% |
| Cost of Revenue | -11.82% | 0.92% | 25.51% | 50.32% | 205.51% |
| Gross Profit | 7.01% | 3.66% | 35.11% | 86.21% | 211.14% |
| SG&A Expenses | -19.81% | -8.12% | -10.48% | -11.26% | 3,643.35% |
| Depreciation & Amortization | -18.42% | -31.99% | -38.24% | -23.73% | -28.71% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.01% | -2.20% | 12.95% | 27.66% | 252.29% |
| Operating Income | 42.22% | 21.12% | 38.15% | 41.90% | -5.76% |
| Income Before Tax | 82.33% | -103.63% | -76.72% | -64.89% | -165.35% |
| Income Tax Expenses | 131.07% | 85.10% | 59.98% | -138.97% | -295.74% |
| Earnings from Continuing Operations | 81.16% | -109.72% | -78.89% | -62.95% | -151.10% |
| Earnings from Discontinued Operations | 45.86% | 45.82% | 48.37% | 34.53% | -102.59% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 257.74% | 250.25% | 224.89% | 219.54% | -48.63% |
| Net Income | 77.26% | 26.33% | 30.86% | 20.89% | 0.67% |
| EBIT | 42.22% | 21.12% | 38.15% | 41.90% | -5.76% |
| EBITDA | 41.62% | 12.64% | 36.37% | 39.73% | -3.89% |
| EPS Basic | 75.29% | 26.16% | 30.43% | 20.69% | 17.31% |
| Normalized Basic EPS | 142.81% | 106.53% | 95.49% | 91.85% | -196.08% |
| EPS Diluted | 75.29% | 26.16% | 30.43% | 20.69% | 17.31% |
| Normalized Diluted EPS | 142.81% | 106.53% | 95.49% | 91.85% | -196.08% |
| Average Basic Shares Outstanding | 2.78% | 2.16% | 1.55% | 1.07% | 11.19% |
| Average Diluted Shares Outstanding | 2.78% | 2.16% | 1.55% | 1.07% | 11.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
